RIVANNA

02/03/2026

Great energy at North Fork as Charlottesville's MedTech, diagnostics, and digital health innovators show off what they've been building. Love seeing this community come together at the CvilleBioHub 3rd Annual Device & Tech Expo!

RIVANNA is ready to share our AI-powered imaging technology that brings diagnostic clarity to the point of care — from neuraxial guidance to fracture detection in the ED.

🚀 Two devices in the FDA pipeline. 📍Built right here in Charlottesville.

01/29/2026

Maternal age is rising. Obesity affects nearly 30% of pregnant patients. Medical complexity has become the norm rather than the exception. Anesthesiology providers face technical challenges that palpation alone cannot reliably solve. What role does ultrasound-guided technology play in meeting this moment?

🔔 Follow us to learn more about how Accuro 3S supports neuraxial procedures.

Discover why rising maternal age, obesity, and cesarean rates are increasing the need for first-attempt neuraxial success in obstetric anesthesia care.

01/28/2026

Ready for every critical moment. ⏱️🏥

The safety patients experience today is the result of decades of physician-led discoveries, from safer airway protocols to advanced hemodynamic monitoring.

To the physicians who stand ready at the head of the table, combining deep expertise with modern innovation: We celebrate you today and every day!

As a proud ASA Innovator Supporter, RIVANNA joins The American Society of Anesthesiologists (ASA) in raising awareness of the importance of anesthesiologist-led innovations and advancements.

01/27/2026

Honoring a history of breakthroughs. 🏛️✨

As we celebrate Physician Anesthesiologists Week 2026, we're reflecting on the profound impact this specialty has had on the history of medicine.

The theme "Anesthesiologists Powering Innovation, Made for This Moment" couldn't be more fitting. Every major advancement in surgery—from open-heart procedures to complex organ transplants—was made possible because anesthesiologists found a safer, better way to protect the patient.

To the physicians who continue to push the boundaries of what's possible: We salute your expertise and your vision. As a proud ASA Innovator Supporter, RIVANNA joins The American Society of Anesthesiologists (ASA) in raising awareness of the importance of anesthesiologist-led innovations and advancements.

01/26/2026

Celebrating the innovators behind the drapes. 😷💡

This week, we celebrate Physician Anesthesiologists Week 2026 and its fitting theme: "Anesthesiologists Powering Innovation, Made for This Moment."

Anesthesiology is a specialty defined by pivotal breakthroughs that changed the course of medicine. At RIVANNA, it's been our privilege to support this drive for excellence. As a proud ASA Innovator Supporter, we're committed to elevating the standard of care by equipping clinicians with technology that makes neuraxial guidance safer, faster, and more precise.

We join The American Society of Anesthesiologists (ASA) in spotlighting anesthesiologist-led innovation. Thank you to all physician anesthesiologists for advancing patient care.

01/24/2026

Proud to be at ASA ADVANCE 2026 as an ASA Innovator Supporter, learning from the community and exploring how RIVANNA can continue advancing patient safety and quality improvement. A snapshot of yesterday's innovation pitch competition—featuring an incredible panel of judges, including RIVANNA's Craig Loomis.

01/23/2026

RIVANNA is headed to ASA ADVANCE 2026 in Las Vegas.

Our team will be connecting with ASA leadership and thought leaders across the anesthesiology community. We're excited to learn and continue exploring how RIVANNA can best support ASA's mission to improve patient safety through innovation.

See you there!

01/22/2026

An estimated 1.1 million pregnant women in the United States have a BMI over 30, making obesity perhaps the most significant anatomical challenge facing anesthesiology providers today. When body habitus obscures surface landmarks, traditional palpation methods may offer limited guidance for neuraxial placement.

Research demonstrates that obesity can substantially increase the technical difficulty of neuraxial procedures, extend placement time, and reduce first-attempt success rates. For providers, this means confronting anatomical complexity in nearly one out of every three patients who arrive in labor and delivery.

The challenge isn't theoretical. When landmarks disappear beneath tissue depth, providers face a choice: rely on palpation alone and accept multiple attempts, or use technology that visualizes what touch cannot detect. Pre-procedural ultrasound can pe*****te tissue depth to map spinal anatomy that otherwise remains undetectable.

Studies confirm that for high-BMI patients, ultrasound identification of the midline and optimal insertion site may prove especially valuable. In a patient population where approximately 30% present with obesity — and that percentage continues to climb — pre-procedural imaging may play an increasingly important role in clinical practice.

🔁 Share to support precision in complex neuraxial cases.
🔔 Follow RIVANNA for clinical insights on obstetric anesthesia.

01/20/2026

Reflecting on an 🌟 energizing JP Morgan Healthcare Week in San Francisco: RESI JPM is Life Science Nation's premier investor and external innovation partnering event, where Will Mauldin & Delphine Le Roux had the opportunity to participate in high-energy discussions with investors exploring the future of medtech.

Organizations like MedTech Innovator and AdvaMed play such a critical role in helping emerging medtech companies grow and thrive. We're grateful for the doors they've opened and the community they've built.

Thank you to our incredible RIVANNA team, whose dedication makes moments like this possible. 🚀

01/20/2026

The United States cesarean delivery rate is 32%, representing around 1.2 million procedures each year. For anesthesiology providers, this statistic translates to nearly 1.2 million opportunities where neuraxial anesthesia placement directly impacts patient comfort, procedure efficiency, and clinical outcomes.
Regional anesthesia forms the foundation of cesarean anesthesia care, offering advantages over general anesthesia that may include reduced maternal risk, improved pain control, and enhanced early bonding opportunities. However, these benefits depend fundamentally on accurate placement.
First-attempt success matters. Each additional needle pass may increase patient discomfort, extend procedure time, and raise the risk of complications, including post-dural puncture headache (PDPH). In anatomically complex cases — patients with obesity, scoliosis, or prior spinal surgery — landmark identification through palpation alone may become unreliable.
Pre-procedural ultrasound imaging helps address this challenge by providing anatomical visualization before needle insertion. Research demonstrates that ultrasound guidance can reduce placement failures and improve first-attempt success compared to landmark-based techniques alone.
When nearly one in three births requires cesarean delivery, technologies that enhance neuraxial precision may support better outcomes.
🔔 Follow RIVANNA for insights on obstetric anesthesia innovation.

01/12/2026

We’re heading to RESI JPM 2026!

Will Mauldin, PhD, Co-founder & CEO of RIVANNA, and Delphine Le Roux, PhD, PMP, Senior Director of Market Access & Strategic Partnerships, will be attending to meet with investors and strategic partners during JPM week.

RIVANNA develops AI-guided, radiation-free ultrasound platforms that address persistent gaps in point-of-care imaging, with a focus on advanced spinal and musculoskeletal applications. Our commercial-stage technology platform supports real-time procedural guidance and rapid bedside assessment—designed to improve clinical workflows, expand access, and scale across diverse care settings.

Backed by clinically grounded development, a strong IP foundation, and substantial non-dilutive support from U.S. government partners, we are advancing a portfolio positioned for partnership-driven commercialization.

If you’re attending RESI JPM and exploring strategic partnerships, investment opportunities, or platform technologies in medical imaging and diagnostics, we’d welcome the conversation.

01/08/2026

With more than three decades in obstetric anesthesia, Dr. Steven Garber has seen technology transform how clinicians deliver care. Yet few innovations have inspired him like RIVANNA’s Accuro 3S. After serving as an early adopter and clinical collaborator, Dr. Garber calls the system’s AI-enhanced, hands-free ultrasound and live needle tracking “a true game-changer” for challenging epidurals.

Accuro 3S is designed to help anesthesiologists identify anatomy, track the needle in real time, and approach each case with greater confidence, particularly in patients with high BMI or complex spines. For Dr. Garber, this evolution isn’t about replacing skill; it’s about augmenting it. “We’re going to be safer, more efficient, and more precise,” he says. “It’s an exciting time to be an obstetric anesthesiologist.”

🔔 Follow us to hear from more experts like Dr. Garber



https://rivannamedical.com/advancing-obstetric-anesthesia-dr-steven-garber-on-the-real-world-power-of-accuro-3s/

Obstetric anesthesiologist Dr. Steven Garber shares how the AI-powered Accuro 3S can enhance epidural precision, efficiency, and patient safety.